granted
on 30 Jul 2024
Last Applicant/ Owned by
50 FEATHERSTONE STREET
LONDON
GB
EC1Y8RT
Serial Number
90523956 filed on 10th Feb 2021
Registration Number
N/A
Correspondent Address
Thomas J. Romano
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Consultancy in the field of pharmaceutical research; consultancy in the field of scientific research; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research and development services; testing of pharmaceuticals; scientific laboratory services; scientific advisory services; sci Read More
Advisory services relating to intellectual property protection; intellectual property consultancy; intellectual property consultancy services in the field of patents and patent applications; legal consultancy relating to patent mapping; licensing of intellectual property; legal administration of licences; copyright management
N/A
N/A
Pharmaceutical advisory services; pharmaceutical consultation; pharmaceutical compounding services; pharmacy advisory services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; psychological support and mental health therapy services
N/A
N/A
Consultancy in the field of pharmaceutical research; consultancy in the field of scientific research; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research and development services; testing of pharmaceuticals; scientific laboratory services; scientific advisory services; scientific and industrial research in the field of pharmaceuticals and healthcare; scientific investigations for medical purposes; scientific research services for medical purposes; advisory services relating to scientific research; scientific research in the field of pharmacy; scientific and technological research relating to patent mapping; Scientific and technological services, namely, compiling statistical data in the field of medical and scientific research
N/A
N/A
Advertising and marketing; business advisory services relating to the commercial exploitation of inventions; advisory services relating to business management and business operations; providing commercial and business contact information; assistance and advice regarding business organisation and management; business consulting services in the field of product development; wholesale and retail store services featuring pharmaceutical preparations, neuro-pharmaceutical preparations, medical, veterinary and sanitary preparations, apparatus and instruments and medical supplies; compilation of statistical data for use in scientific research for business purposes; compilation of statistical data relating to medical research for business purposes
N/A
N/A
Medical apparatus for use in treating respiratory diseases and conditions; medical devices for use in treating respiratory diseases and conditions; medical apparatus for facilitating the inhalation of pharmaceutical preparations; inhalers for medical use; inhalers for therapeutic use, sold empty; vaporizers for medical purposes; medical apparatus, namely, electric vaporizer for treatment of upper respiratory conditions; nebulizers for administering medication in the form of a mist inhaled into the lungs, for treatment of respiratory diseases and conditions; respiratory masks for medical purposes; medical fluid injectors; needle-based and needle-free injection systems; injection device for pharmaceuticals
N/A
N/A
Pharmaceutical preparations for treating mental health conditions, depression, anxiety, stress, bipolar affective disorder, body dysmorphia, eating disorders, insomnia, hormonal disorders, sleep disorders, obsessive compulsive disorder, attention deficit hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD), psychosis, schizophrenia, dissociative disorders, substance abuse disorders, gambling disorders, neurological conditions and disorders, stroke, Parkinson's disease, Alzheimer's disease, dementia, headaches, migraine, pain conditions, fibromyalgia, neuropathy pain, epilepsy, and non-epileptic seizures; medical preparations for treating mental health conditions, depression, anxiety, stress, bipolar affective disorder, body dysmorphia, eating disorders, insomnia, hormonal disorders, sleep disorders, obsessive compulsive disorder, attention-deficit/hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD), psychosis, schizophrenia, dissociative disorders, substance abuse disorders, gambling disorders, neurological conditions and disorders, stroke, Parkinson's disease, Alzheimer's disease, dementia, headaches, migraine, pain conditions, fibromyalgia, neuropathy pain, epilepsy, and non-epileptic seizures; neuro-pharmaceutical preparations for treating mental health conditions, depression, anxiety, stress, bipolar affective disorder, body dysmorphia, eating disorders, insomnia, hormonal disorders, sleep disorders, obsessive compulsive disorder, attention-deficit/hyperactivity disorder (ADHD), post-traumatic stress disorder (PTSD), psychosis, schizophrenia, dissociative disorders, substance abuse disorders, gambling disorders, neurological conditions and disorders, stroke, Parkinson's disease, Alzheimer's disease, dementia, headaches, migraine, pain conditions, fibromyalgia, neuropathy pain, epilepsy, and non-epileptic seizures
N/A
N/A
No 90523956
No Service Mark
No IPL403
Yes
No
No
No
No
No
No
No
01.15.06 -
Clouds, fog
26.15.21 -
Polygons that are completely or partially shaded
Status Date | Action Taken |
---|---|
30th Jul 2024 | SOU EXTENSION 4 FILED |
30th Jul 2024 | SOU EXTENSION 4 GRANTED |
30th Jul 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
30th Jul 2024 | SOU TEAS EXTENSION RECEIVED |
28th Feb 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
26th Feb 2024 | ASSIGNED TO EXAMINER |
02th Feb 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
31st Jan 2024 | SOU TEAS EXTENSION RECEIVED |
31st Jan 2024 | SOU EXTENSION 3 GRANTED |
31st Jan 2024 | SOU EXTENSION 3 FILED |